*National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; †Field Epidemiology and Laboratory Training Programme, Ministry of Health, Nairobi, Kenya; ‡Global Health Sciences, University of California, San Francisco, CA; §Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya; and ‖National Public Health Laboratory Services, Ministry of Health, Nairobi, Kenya.
J Acquir Immune Defic Syndr. 2014 May 1;66 Suppl 1(Suppl 1):S66-74. doi: 10.1097/QAI.0000000000000115.
Kenya has an estimated 13,000 new infant HIV infections that occur annually. We measured the burden of HIV infection among women of childbearing age and assessed access to and coverage of key prevention of mother-to-child transmission interventions.
The second Kenya AIDS Indicator Survey was a nationally representative 2-stage cluster sample of households. We analyzed data from women aged 15-54 years who had delivered a newborn within the preceding 5 years and from whom we obtained samples for HIV testing.
Of 3310 women who had ≥1 live birth in the preceding 5 years, 2862 (86.5%) consented to HIV testing in the survey, and 171 (6.1%) were found to be infected. Ninety-five percent received prenatal care, 93.1% were screened for HIV during prenatal care, and of those screened, 97.8% received their test results. Seventy-six women were known to be infected in their last pregnancy. Of these, 54 (72.3%) received antepartum antiretroviral prophylaxis, and 51 (69.1%) received intrapartum prophylaxis; 56 (75.3%) reported their newborns received postpartum prophylaxis. Of the 76 children born to these mothers, 63 (82.5%) were tested for HIV at the first immunization visit or thereafter, and 8 (15.1%) were HIV infected.
We found a substantial burden of HIV in Kenyan women of childbearing age and a cumulative 5-year mother-to-child transmission rate of 15%. Although screening has improved over the past 5 years, fewer than three-quarters of infected pregnant women are receiving antiretroviral prophylaxis. Universal antiretroviral therapy for HIV-infected pregnant women will be essential in achieving Kenyan's target to eliminate mother-to-child transmission to <5% by 2015.
肯尼亚每年约有 13000 例新的婴儿 HIV 感染。我们测量了育龄妇女中 HIV 感染的负担,并评估了获得和覆盖预防母婴传播关键干预措施的情况。
肯尼亚艾滋病指标调查是一项全国代表性的 2 阶段聚类抽样家庭调查。我们对在过去 5 年内分娩过新生儿且从其获得 HIV 检测样本的年龄在 15-54 岁的妇女进行了数据分析。
在过去 5 年内有≥1 次活产的 3310 名妇女中,2862 名(86.5%)在调查中同意进行 HIV 检测,171 名(6.1%)检测结果呈阳性。95%的人接受了产前保健,93.1%在产前保健期间接受了 HIV 筛查,在接受筛查的人中,97.8%获得了检测结果。76 名妇女在最后一次妊娠时被确诊为感染。其中,54 名(72.3%)接受了产前抗逆转录病毒预防,51 名(69.1%)接受了产时预防;56 名(75.3%)报告说她们的新生儿接受了产后预防。在这些母亲所生的 76 名儿童中,63 名(82.5%)在首次免疫接种就诊或之后接受了 HIV 检测,8 名(15.1%)感染了 HIV。
我们发现肯尼亚育龄妇女 HIV 负担很大,5 年内母婴传播累计率为 15%。尽管过去 5 年来筛查有所改善,但不到四分之三的感染孕妇接受抗逆转录病毒预防。对感染 HIV 的孕妇进行普遍的抗逆转录病毒治疗,对于实现肯尼亚到 2015 年将母婴传播率降低到<5%的目标至关重要。